Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 12;2(3):338-340.
doi: 10.1016/j.jacasi.2021.12.003. eCollection 2022 Jun.

Residual Inflammatory Risk After Percutaneous Coronary Intervention: Underappreciated But Modifiable

Anna van Veelen  1 , José P S Henriques  1 , Bimmer E P M Claessen  1
Affiliations
Editorial

Residual Inflammatory Risk After Percutaneous Coronary Intervention: Underappreciated But Modifiable

Anna van Veelen et al. JACC Asia. .
No abstract available

Keywords: c-reactive protein; cardiovascular risk; percutaneous coronary intervention; residual inflammatory risk.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jacasi.2021.11.014

References

    1. Kufner S., Joner M., Thannheimer A., et al. Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease. Circulation. 2019;139:325–333. - PubMed
    1. Cutlip D.E., Chhabra A.G., Baim D.S., et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004;110:1226–1230. - PubMed
    1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672. - PubMed
    1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143. - PubMed
    1. Visseren F.L.J., Mach F., Smulders Y.M., et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC) Eur Heart J. 2021;42:3227–3337. - PubMed

Publication types